Medicine News and Research

RSS

Study Reveals Mitochondria Plug Straight Into the Nuclear Command

For generations, textbooks have taught that a cell's energy simply drifts to wherever it is needed.

11 Jun 2026

New Cell Therapy Modifies Natural Killer Cells Against Cancer

Scientists have made great progress in harnessing the body's own immune cells to treat so-called liquid tumors, cancers of the blood and lymphatic system.

11 Jun 2026

Computational Tool Enhances Reliability of DNA Nano-Vehicles for Medicine

Scaffolded DNA and RNA origami is a technology that enables scientists to create tiny, very precise two and three-dimensional objects.

10 Jun 2026

Researchers Outline Dynamic Protein Control Systems for Better Clinical Decisions

Cancer has often been explained through mutations in deoxyribonucleic acid (DNA) or changes in ribonucleic acid (RNA), but these layers do not fully explain why tumors with similar genetic profiles can behave differently.

10 Jun 2026

Coffee Can Now Serve as a Biological Switch for Medicines

For many of us, a warm cup of coffee is how we start our day. For Texas A&M Health researchers, it may also offer a new way to control engineered cells in future medicines.

9 Jun 2026

Microtubule Skeleton Determines How Heart Muscle Cells Change Under Stress

Microtubules, part of heart muscle cells' internal "skeleton," help determine how the heart changes shape under stress, and a common signaling pathway called the ERK pathway acts as a key controller of where the building materials for these cells' growth are delivered inside them, a pair of new studies show.

9 Jun 2026

Scientists Identify EHMT2 Enzyme as Main Cause of 5-FU Failure

One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment that has improved outcomes for countless patients.

9 Jun 2026

First Patient Enrolled in Oncopeptides’ Real-World Evidence Study Marina in Germany

Oncopeptides AB, a biotech company specializing in difficult-to-treat cancers, today announces that the first patient has been enrolled in the new real-world evidence study in Germany, named Marina.

9 Jun 2026

Creatine Linked to Cancer-Fighting Dendritic Cell Function

According to recent UCLA research, creatine, the organic acid that athletes and bodybuilders frequently use as a supplement, supercharges a crucial class of immune cells that activate and prime the body's primary cancer-fighting agents.

8 Jun 2026

New Study Proves Research Models Accurately Replicate Cancer ecDNA Loops

Damage to DNA in cancer cells can lead to pieces breaking off chromosomes and floating away, like icebergs cracking off from a glacier. Just as icebergs are a threat to ships and their crew, these scattered bits of DNA loom large to physicians and cancer patients by having titanic effects on tumor progression and treatment resistance.

8 Jun 2026

Biologists Capture Snapshot of Evolutionary Transition in Y Chromosome Gene

The study, published in Volume 153, Issue 9 of the journal Development on May 14, 2026, by The Company of Biologists, is the first to precisely map endogenous UTY occupancy across the human genome and demonstrate that UTY remains functionally involved in transcriptional regulation during early human development.

8 Jun 2026

Blood Signature Found to Predict Lung Cancer Risk Years Before Diagnosis

Researchers have identified a blood signature that can predict lung cancer risk years before diagnosis – significant findings that could enhance prevention strategies for Australia’s biggest cancer killer.

5 Jun 2026

Scientists Identify Microglia Immune State Changes for Novel Alzheimer’s Therapies

Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical biological transition that may determine whether Alzheimer's disease pathology leads to dementia.

5 Jun 2026

New Antibiotic Compound Blocks Ribosome to Starve Dangerous Pathogens

Researchers at McMaster University have discovered a new antibiotic that kills some of the world's most dangerous and drug-resistant bacteria - and does so by targeting a previously unknown vulnerability, opening the door to an entirely new class of treatments.

5 Jun 2026